文献速递儿科与产科急症

家长接受 COVID-19 疫苗接种的相关因素:多中心儿科急诊横断面分析

Factors Associated With Parental Acceptance of COVID-19 Vaccination: A Multicenter Pediatric Emergency Department Cross-Sectional Analysis.
PubMed 文献 · Ann Emerg Med · 2022-02-01
一句话结论2021 年 delta 变异株流行期间,9 个儿科急诊中 50% 家长及 27% 的 ≥12 岁儿童已接种 COVID-19 疫苗,对科学家的信任与家长及儿童接种接受度关联最强(aOR 5.11 与 5.37)。

研究在 2021 年 6 月至 8 月 delta 变异株流行期间,对 9 个儿科急诊就诊的 3 至 16 岁儿童的家长进行横断面问卷调查,评估其对 COVID-19 疫苗的接受度。1,491 名被接触的家长中 1,298 名(87%)参与,50% 的家长和 27% 的 ≥12 岁儿童已接种疫苗。多变量回归显示,对科学家的信任与家长自身接种(aOR 5.11,95%CI 3.65 至 7.15)及儿童接种或接种意愿(aOR 5.37,95%CI 3.65 至 7.88)关联最强,近期流感疫苗接种、大学学位、家长年龄增长等亦相关。作者结论为总体 COVID-19 疫苗接种接受度低,对科学家的信任与家长自身及子女的疫苗接受度关联最强。

要点

  • 1,298 名家长参与(参与率 87%),50% 的家长已接种 COVID-19 疫苗,27% 的 ≥12 岁儿童已接种。
  • 对科学家的信任与家长自身接种 COVID-19 疫苗独立相关(aOR 5.11,95%CI 3.65 至 7.15)。
  • 对科学家的信任与儿童接种或接种意愿关联最强(aOR 5.37,95%CI 3.65 至 7.88)。
  • 家长近期接种流感疫苗与自身接种(aOR 2.66,95%CI 1.98 至 3.58)及儿童接种或意愿(aOR 1.89,95%CI 1.29 至 2.77)相关。
  • 家长大学学位、年龄增长、亲友因 COVID-19 住院及较高收入与家长自身接种相关(aOR 分别为 1.97、1.80、1.34、1.60)。

适用人群与场景

  • 2021 年 6 月至 8 月就诊于 9 个儿科急诊的 3 至 16 岁儿童的家长。
  • 分析儿童接种或接种意愿时,≥12 岁儿童评估已接种 COVID-19 疫苗,<12 岁儿童评估一旦获批使用后的接种意愿。

研究设计与关键结果

  • 研究类型为多中心横断面问卷调查,9 个儿科急诊,2021 年 6 月至 8 月,1,491 名家长被接触,1,298 名(87%)参与。
  • 50% 的家长已接种 COVID-19 疫苗,27% 的 ≥12 岁儿童已接种。
  • 与家长自身 COVID-19 疫苗接种相关的因素:信任科学家(aOR 5.11,95%CI 3.65 至 7.15)、近期流感疫苗接种(aOR 2.66,95%CI 1.98 至 3.58)、大学学位(aOR 1.97,95%CI 1.36 至 2.85)、家长年龄增长(aOR 1.80,95%CI 1.45 至 2.22)、亲友因 COVID-19 住院(aOR 1.34,95%CI 1.05 至 1.72)、较高收入(aOR 1.60,95%CI 1.27 至 2.00)。
  • 与儿童 COVID-19 疫苗接种(≥12 岁)或获批后接种意愿(<12 岁)相关的因素:家长信任科学家(aOR 5.37,95%CI 3.65 至 7.88)、近期流感疫苗接种(aOR 1.89,95%CI 1.29 至 2.77)、信任媒体(aOR 1.68,95%CI 1.19 至 2.37)、家长大学学位(aOR 1.49,95%CI 1.01 至 2.20)、家长年龄增长(aOR 1.26,95%CI 1.01 至 1.57)。

证据类型、等级与局限

  • 证据类型:多中心横断面问卷调查。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:总体 COVID-19 疫苗接种接受度低;对科学家的信任与家长自身及子女的疫苗接受度关联最强。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: During the delta surge of the COVID-19 pandemic in 2021, we sought to identify characteristics and beliefs associated with COVID-19 vaccination acceptance in parents of pediatric emergency department (ED) patients.

METHODS: We conducted a cross-sectional survey-based study of the parents of children aged 3 to 16 years presenting to 1 of 9 pediatric EDs from June to August 2021 to assess the parental acceptance of COVID-19 vaccines. Using multiple variable regression, we ascertained which factors were associated with parental and pediatric COVID-19 vaccination acceptance.

RESULTS: Of 1,491 parents approached, 1,298 (87%) participated, of whom 50% of the parents and 27% of their children aged 12 years or older and older were vaccinated. Characteristics associated with parental COVID-19 vaccination were trust in scientists (adjusted odds ratio [aOR] 5.11, 95% confidence interval [CI] 3.65 to 7.15), recent influenza vaccination (aOR 2.66, 95% CI 1.98 to 3.58), college degree (aOR 1.97, 95% CI 1.36 to 2.85), increasing parental age (aOR 1.80, 95% CI 1.45 to 2.22), a friend or family member hospitalized because of COVID-19 (aOR 1.34, 95% CI 1.05 to 1.72), and higher income (aOR 1.60, 95% CI 1.27 to 2.00). Characteristics associated with pediatric COVID-19 vaccination (children aged ≥12 years) or intended COVID-19 pediatric vaccination, once approved for use, (children aged <12 years) were parental trust in scientists (aOR 5.37, 95% CI 3.65 to 7.88), recent influenza vaccination (aOR 1.89, 95% CI 1.29 to 2.77), trust in the media (aOR 1.68, 95% CI 1.19 to 2.37), parental college degree (aOR 1.49, 95% CI 1.01 to 2.20), and increasing parental age (aOR 1.26, 95% CI 1.01 to 1.57).

CONCLUSION: Overall COVID-19 vaccination acceptance was low. Trust in scientists had the strongest association with parental COVID-19 vaccine acceptance for both themselves and their children.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Baumann BM, Rodriguez RM, DeLaroche AM, et al. Factors Associated With Parental Acceptance of COVID-19 Vaccination: A Multicenter Pediatric Emergency Department Cross-Sectional Analysis. Ann Emerg Med. 2022. PMID: 35525709. doi:10.1016/j.annemergmed.2022.01.040

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。